Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04899947 · ClinicalTrials.gov registry record
Child and Adolescent Registry for Participants With Narcolepsy
A clinical trial of Narcolepsy, sponsored by Jazz Pharmaceuticals.
- Recruiting
- Registry status
- 500
- Enrollment target
- 20
- Study locations
NCT04899947 is a study of Narcolepsy that is actively recruiting participants, run by Jazz Pharmaceuticals. The registered enrollment target is 500 participants, above the 339-participant average among 12 other Narcolepsy trials with a reported enrollment target (47% higher). The trial reports 20 study locations across 12 states.
The verdict
NCT04899947, a study of Narcolepsy, is actively recruiting participants, sponsored by Jazz Pharmaceuticals.
- RECRUITING
- Registry status
- 500 participants
- Enrollment target
- 20
- Study locations
Study Summary
CATNAP is a patient registry designed to improve the understanding of the natural history of narcolepsy in pediatric patients. Descriptive statistics on disease characteristics will be performed. The study has 16 active clinical sites and a virtual site that widens participation to anywhere in the United States. For more information about the study or to access the Online Patient Enrollment System, visit the CATNAP website: https://catnap.healthie.net/welcome or email catnap@pulseinfoframe.com. The Online Patient Enrollment System, CATNAP website, can also be found in the references section.
Conditions Studied
Study Locations (20)
Ohio
- Cincinnati Children's Hospital Medical Center - Cincinnati
- University Hospitals Cleveland Medical Centre (UHCMC) - Cleveland
- Nationwide Children's Hospital - Columbus
Arizona
- Phoenix Children's Hospital - Phoenix
- University of Arizona - Tucson
Arkansas
- University of Arkansas - Fayetteville
- Arkansas Children's Research Institute - Little Rock
California
- Stanford University - Redwood City
- University of California San Diego - San Diego
District of Columbia
- Children's National Medical Center - Washington D.C.
- Children's Research Institute - Washington D.C.
Michigan
- Trinity Health-Michigan - Grand Rapids
- Mayo Clinic - Rochester
Missouri
- St. Luke's Hospital - Chesterfield
- Children's Mercy Hospital - Kansas City
Florida
- University of South Florida - Tampa
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 500 participants |
| Start Date | 2020-10-10 |
| Est. Completion | 2024-10-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04899947
The ClinicalTrials.gov registry entry for NCT04899947 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 500 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 339-participant average among 12 other Narcolepsy trials with a reported enrollment target (47% higher). The listed sponsor is Jazz Pharmaceuticals, which has 128 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Narcolepsy appearing as the primary indexed condition, and to 0 interventions.
NCT04899947 reports 20 study locations spanning 12 distinct geographic areas - top geographies include Ohio, Arizona, Arkansas.
Frequently Asked Questions
What is clinical trial NCT04899947 about?
NCT04899947 is a clinical study titled "Child and Adolescent Registry for Participants With Narcolepsy". CATNAP is a patient registry designed to improve the understanding of the natural history of narcolepsy in pediatric patients. Descriptive statistics on disease characteristics will be performed. The study has 16 active clinical sites and a virtual site that widens participation to anywhere in the ...
What is the current status of trial NCT04899947?
This trial is currently recruiting. The enrollment target is 500 participants. The study started on 2020-10-10. Estimated completion is 2024-10-01.
What conditions does trial NCT04899947 study?
This clinical trial studies the following conditions: Narcolepsy.
Who is sponsoring clinical trial NCT04899947?
This trial is sponsored by Jazz Pharmaceuticals, which has 128 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04899947 being conducted?
This trial has 20 study locations across Arizona, Arkansas, California, District of Columbia, Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Narcolepsy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
SUNOSI® (Solriamfetol) Pregnancy Registry
RECRUITING
-
A Study to Investigate Efficacy, Safety, Tolerability, and Pharmacokinetics of JZP441 Compared With Placebo in Participants With Narcolepsy Type 1
RECRUITING · Phase 1
-
WAKIX® (Pitolisant) Pregnancy Registry
RECRUITING
-
A Study of the Safety and Effectiveness of ADX-N05 for Excessive Daytime Sleepiness in Subjects With Narcolepsy
COMPLETED · Phase 2
-
Narcolepsy Nightmare Study
COMPLETED · NA
-
Psychosocial Adjunctive Treatment for Hypersomnia (PATH)
COMPLETED · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.